维普中文期刊产品整合服务
38篇 您的检索式:作者名="Roderich"
    题名 作者 年代 出处 被引量
1Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer显示文摘AIM: To compare the efficacy of capecitabine and oxaliplatin (XELOX) with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX6) in gastric cancer patients after D2 dissection. METHODS: Between May 2004 and June 2010, patients in our gastric cancer database who underwent D2 dissection for gastric cancer at the First Affiliated Hospital of Sun Yat-Sen University were retrospectively analyzed. A total of 896 patients were enrolled into this study according to the established inclusion and exclusion criteria. Of these patients, 214 received the XELOX regimen, 48 received FOLFOX6 therapy and 634 patients underwent surgery only without chemotherapy. Overall survival was compared among the three groups using Cox regression and propensity score matchedpair analyses. RESULTS: Patients in the XELOX and FOLFOX6 groups were younger at the time of treatment (median age 55.2 years; 51.2 years vs 58.9 years), had more undifferentiated tumors (70.1%; 70.8% vs 61.4%), and more lymph node metastases (80.8%; 83.3% vs 57.7%), respectively. Overall 5-year survival was 57.3% in the XELOX group which was higher than that (47.5%) in the surgery only group (P = 0.062) and that (34.5%) in the FOLFOX6 group (P = 0.022). Multivariate analysis showed that XELOX therapy was an independent prognostic factor (hazard ratio = 0.564, P < 0.001). After propensity score adjustment, XELOX significantly increased overall 5-year survival compared to surgery only (58.2% vs 44.2%, P = 0.025) but not compared to FOLFOX6 therapy (48.5% vs 42.7%, P = 0.685). The incidence of grade 3/4 adverse reactions was similar between the XELOX and FOLFOX6 groups, and more patients suffered from hand-foot syndrome in the XELOX group (P = 0.018). CONCLUSION: Adjuvant XELOX therapy is associated with better survival in patients after D2 dissection, but does not result in a greater survival benefit compared with FOLFOX6 therapy.Ying Wu Zhe-Wei Wei Yu-Long He Roderich E Schwarz David D Smith Guang-Kai Xia Chang-Hua Zhang 2013World Journal of Gastroenterology2013,19,21:14
2Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1-3 involved para-aortic nodes显示文摘Zhang Changhua He Yulong Roderich E.Schwarz David D.Smith Wang Liang Liu Fakeng Zhan Wenhua 2014Chinese Medical Journal2014,,3:6
3胃癌腹膜种植瘤动物模型的构建显示文摘目的建立稳定实用的人胃癌鼠腹膜种植瘤模型。方法通过对裸鼠和SCID鼠腹腔注射胃癌细胞株AGS、NCI—N87和SNUl6构建腹膜种植瘤模型,比较不同细胞株模型成功率和生存期的差异。结果裸鼠腹腔种植5×106个AGS、NCI—N87和SNUl6细胞腹膜瘤形成率分别是(3/8、6/8和2/8;SCID鼠腹腔种植5×106个AGS、NCI—N87和SNUl6细胞,腹膜瘤形成率分别是0/6、6/6和6/6。SCID鼠腹膜瘤模型中位生存期:NCI—N87细胞组(10x10。)为74d;SNUl6细胞3个不同剂量组(10×106、20×106和40×106)分别为95、78和44d。结论SCID鼠腹腔种植(20—40)×106个SNUl6细胞可以构建稳定实用的胃癌腹膜种植瘤模型。张常华 陈连周 Roderich Schwarz 曾文涛 吴英 魏哲威 何裕隆 2013中华普通外科学文献(电子版)2013,7,5:3
4Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database显示文摘Roderich E. Schwarz MD David D. Smith PhD 2006Annals of Surgical Oncology2006,,9:2
5Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy显示文摘Roderich E. Schwarz Kathryn Zagala-Nevarez 2002Annals of Surgical Oncology2002,,4:2
6PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer显示文摘Katherine T. Ostapoff Niranjan Awasthi Bercin Kutluk Cenik Stefan Hinz Keith Dredge Roderich E. Schwarz Rolf A. Brekken 2013Molecular Cancer Therapeutics2013,,7:2
7Cooperation through self assembly in multi-robot systems显示文摘Elio T Roderich G Vito T 2006ACM Transactions on Autonomous and Adaptive Systems2006,1,2:1
8Oene Cluster on pAO1 of Arthrobaeter nieotinovorans involved in degrada- tion of the plant alkaloid nieotine: eloning, purification,andcharacterization of 2, 6-dihydroxypyridine 3-hydroxylase 显示文摘Daniel B Cristinel S Roderich B L 2001Jouranl of Bacteriology2001,183,18:1
9Androgen Receptor Blockade in Experimental Combination Therapy of Pancreatic Cancer显示文摘Srivani Konduri Margaret A. Schwarz Danielle Cafasso Roderich E. Schwarz 2007Journal of Surgical Research2007,,2:1
10Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage显示文摘Roderich E. Schwarz David D. Smith 2007Annals of Surgical Oncology2007,,2:1
11Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in degradation of the plant alkaloid nicotine: cloning, purification, and characterization of 2, 6 dihydroxypyridine 3-hydroxylase 显示文摘DANIEL B CRISTINEL S RODERICH B 2001Jouranl of Bacteriology2001,183,:1
12The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumorresponse in experimental gastric cancer显示文摘Chang-Ηua Zhang Niranjan Awasthi Margaret Schwarz Roderich Schwarz 2013International Journal of Oncology2013,,5:1
13Paint - Only Is Equivalent to Scrub - and - Paint in Preoper-ative Preparationof Abdominal Surgery Sites 显示文摘Joshua DI Ellenhom David D Smith Roderich E Schwarz etal 2005J Am CoilSurg2005,201,5:1
14Outcome of Palliative Operations for Malignant Bowel Obstruction in Patients With Peritoneal Carcinomatosis From Nongynecological Cancer显示文摘Sarah L. Blair David Z. J. Chu Roderich E. Schwarz 2001Annals of Surgical Oncology2001,,8:1
15Recurrence pattern after radical gastrectomy for gastric cancer:prognostic factors and implications for postoperative asjuvant therapy显示文摘Roderich ES Kathryn ZN 2002Ann Sury Oncol2002,,9:1
16Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage显示文摘Roderich E. Schwarz David D. Smith 2007Annals of Surgical Oncology2007,,2:1
17Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database显示文摘Roderich E. Schwarz David D. Smith 2006Annals of Surgical Oncology2006,,9:1
18Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy显示文摘Roderich E. Schwarz MD PhD Kathryn Zagala-Nevarez PA 2002Annals of Surgical Oncology2002,,4:1
19An organizational learning framework:form intuition to institution 显示文摘MARY M CROSSAN HENRY W LANE RODERICH E WHITE 1999Academy ot7 Management1999,24,52:1
20Recurrence patterns after radical gastrectomy for gastric cancer,prognostic factors and implications for postoperative adjuvant therapy显示文摘Roderich E Schwarz Kathryn Zagala-Nevarez 0,,04:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费